Abstract:Objective:To investigate the effect of transurethral prostatectomy (TURP) on patients with detrusor underactivity (DU).Methods:From January 2015 to January 2019, 72 male patients from Peking University People’s hospital who underwent TURP treatment were retrospectively analyzed. The age of all patients range from 51 to 89, with an average age of 72 years old. All patients underwent urodynamic examination before surgery. The patients were divided into three groups according to BCI and P detQmax. DU group(BCI<100 and P detQmax≤40 cmH 2O) consisted of 31 patients. Then DU patients were divided into two groups according to the P detQmax: Group A, P detQmax≤20 cmH 2O, involving 9 patients; Group B, 20 cmH 2O<P detQmax≤40 cmH 2O, involving 22 patients. Non-DU group(BCI≥100 and 40 cmH 2O<P detQmax≤60 cmH 2O), also named the control GroupC, included 41 patients. There was no statistically significant difference in term of age and duration of disease among the three groups ( P<0.05). Preoperative international prostate symptom scores(IPSS)of the three groups were(26.40±5.54), (21.04±4.61)and(18.53±4.41), respectively. The quality of life score (QOL) were(4.70±1.34), (3.37±1.11)and(3.49±1.34), respectively. The Q max were(4.60±2.63), (8.48±2.47)and(11.38±4.00)ml/s, respectively. The residual urine volume (PVR) were(152.90±75.26), (90.78±51.97)and(53.23±38.98)ml, respectively. The preoperative IPSS and QOL of patients in group A were significantly higher than those in group B and group C, and the difference was statistically significant ( P<0.05), whereas the difference between group B and group C was not statistically significant ( P>0.05). The preoperative Q max of group A was significantly inferior than that of group B and C, with statistically significant difference ( P<0.05) and group B was significantly inferior than group C, with statistically significant difference ( P<0.05). The preoperative PVR of group A was significantly higher than that of group B and group C, with statistically significant difference ( P<0.05)and group B was significantly higher than group C, with statistically significant difference ( P<0.05). The above indicators were followed up to compare the improvement for the three groups of patients. Seventy-two patients were followed up for free Q max(fQ max) PVR, IPSS and QOL score from March 2019 to June 2019. Results:The 72 patients were followed up for 3 to 52 months, with an average of 31.1 months. Postoperative IPSS of the three groups were(25.50±2.84), (16.78±4.04)and(14.98±3.41), respectively. The QOL were (2.90±1.29), (2.67±0.88)and(2.53±0.92), respectively. The fQ max was (5.44±2.60), (10.30±3.68)and(13.07±3.51) ml/s, respectively, and PVR was(104.00±46.00), (76.81±46.74)and(35.64±26.17)ml, respectively. Compared with the preoperative parameters, QOL in group A was significantly improved, with statistically significant difference ( P<0.05) and the IPSS, fQ max and PVR in group A were improved, but the difference was not statistically significant ( P>0.05). The IPSS, QOL, fQ max and PVR in group B and C were significantly improved compared with the preoperative parameters, and the difference was statistically significant ( P<0.05). Conclusions:The subjective and objective indicators of DU patients can be improved after TURP, while for those patients whose P detQmax≤20 cmH 2O, only QOL can be improved significantly, and the other indicators can not be improved. Therefore, adequate communication should be made before surgery to inform reasonable expectations for the DU patients.

Transurethral Resection of Prostate Postoperative IPSS Improvement Survey

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

[Changes of Urinary Symptoms after Transurethral Resection of the Prostate and Its Correlation with Clinical Parameters].

The Effect of Transurethral Resection of the Prostate on Erectile Function

Analysis of Improved Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate

The value of urodynamic examination and IPSS to anticipate the effect of transurethral prostate resection

Clinical analysis and measures on voiding smoothly symptoms of patients following transurethral prostatic resection

Effects of sexual function of TURP and TUIBN

Intravesical prostatic protrusion predicts the outcomes of TURP in patients with BPH

The Effect of Transurethral Resection of the Prostate on Erectile and Ejaculatory Functions in Patients with Benign Prostatic Hyperplasia

Predictive Value of Postoperative Ultrasonographic Parameters Regarding the Outcome after TURP for Patients with Symptomatic BPH

Long-term Outcome of Transurethral Resection of Prostate in Patients with Advanced Prostate Cancer and Bladder Outlet Obstruction

Significance of Prostate Related Factors by TRUS for Predicting Outcome of TURP

Study on the relationship between chronic prostatitis and lower urinary tract symptoms and bladder neck contracture after transurethral resection of the prostate

Transurethral Resection of the the Prostate for Lower Urinary Tract Obstruction from Advanced Prostate Cancer

Effects of Transurethral Resection of Prostate and Plasmakinetic Resectionof Prostate on Patients' Health Related Quality of Life

Study on the efficacy and safety of Transurethral enucleation and resection of the prostate in treatment of IV grade Benign prostatic hyperplasia

The clinical effect of TURP in patients with detrusor underactivity: a short-term follow-up

Multivariate Analysis On Improvement Of Nocturia In Patients With Benign Prostatic Hyperplasia After Transurethral Plasmakinetic Prostatectomy

Impact of transurethral resection of the prostate on erectile function in benign prostatic hyperplasia patients: a descriptive study at a tertiary care hospital